Curanex Pharmaceuticals (CURX) Assets (2024 - 2026)

Curanex Pharmaceuticals (CURX) has reported Assets for 3 consecutive years, with $5.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets rose 544.58% year-over-year to $5.1 million; the trailing twelve-month figure through Jun 2026 stood at $5.1 million (up 544.58% YoY), and the FY2025 full-year result was $11.6 million, up 2135.83% from the prior year.
• Assets eased to $5.1 million in Q2 2026 per CURX's latest filing, from $11.6 million in the prior quarter.
• Across five years, Assets topped out at $14.5 million in Q3 2025 and bottomed at $517935.0 in Q4 2024.
• Historically, Assets has averaged $6.5 million across 3 years, with a median of $5.1 million in 2026.
• The sharpest annual moves came in 2025 and 2026: Assets surged 2135.83% in 2025, then jumped 544.58% in 2026.
• Over 3 years, Assets stood at $517935.0 in 2024, then soared by 2135.83% to $11.6 million in 2025, then tumbled by 56.18% to $5.1 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $5.1 million, $11.6 million, and $14.5 million for Q2 2026, Q4 2025, and Q3 2025 respectively.